Total Payments
$12,124
2024 Payments
$1,128
Companies
55
Transactions
788
Medicare Patients
27,778
Medicare Billing
$2.6M
Payment Breakdown by Category
Food & Beverage$12,099 (99.8%)
Education$25.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,099 | 787 | 99.8% |
| Education | $25.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,532 | 98 | $0 (2024) |
| ABBVIE INC. | $1,448 | 106 | $0 (2024) |
| PFIZER INC. | $1,146 | 100 | $0 (2024) |
| Novo Nordisk Inc | $800.42 | 53 | $0 (2024) |
| Merck Sharp & Dohme LLC | $727.58 | 61 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $544.50 | 42 | $0 (2024) |
| Amgen Inc. | $539.35 | 35 | $0 (2024) |
| Lilly USA, LLC | $439.39 | 33 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $416.18 | 28 | $0 (2021) |
| GlaxoSmithKline, LLC. | $410.09 | 28 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,128 | 64 | ABBVIE INC. ($178.13) |
| 2023 | $1,142 | 72 | AbbVie Inc. ($230.74) |
| 2022 | $1,028 | 64 | ABBVIE INC. ($399.82) |
| 2021 | $1,747 | 104 | AbbVie Inc. ($639.64) |
| 2020 | $1,197 | 63 | AstraZeneca Pharmaceuticals LP ($560.55) |
| 2019 | $1,896 | 134 | AstraZeneca Pharmaceuticals LP ($489.14) |
| 2018 | $1,941 | 130 | AstraZeneca Pharmaceuticals LP ($495.65) |
| 2017 | $2,046 | 157 | AstraZeneca Pharmaceuticals LP ($423.40) |
All Payment Transactions
788 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Biological | ||||||
| 11/25/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Endocrinology | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $31.11 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: UROLOGY | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: Biological | ||||||
| 11/12/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: ANTIBIOTIC | ||||||
| 11/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $1.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Obesity | ||||||
| 10/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Biological | ||||||
| 09/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Inflammation | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Biological | ||||||
| 09/03/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Endocrinology | ||||||
| 08/16/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Endocrinology | ||||||
| 08/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Biological | ||||||
| 07/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Cardiology | ||||||
| 07/23/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Endocrinology | ||||||
| 07/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Biological | ||||||
| 07/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.43 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 48 | 6,086 | 26,435 | $1.5M | $625,814 |
| 2022 | 45 | 7,533 | 33,843 | $1.8M | $724,472 |
| 2021 | 46 | 7,538 | 34,682 | $1.8M | $737,913 |
| 2020 | 46 | 6,621 | 28,133 | $1.5M | $523,553 |
Total Patients
27,778
Total Services
123,093
Medicare Billing
$2.6M
Procedure Codes
185
All Medicare Procedures & Services
185 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,113 | 4,518 | $790,616 | $339,272 | 42.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 413 | 829 | $194,815 | $92,309 | 47.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 257 | 257 | $38,550 | $29,955 | 77.7% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 26 | 2,572 | $64,300 | $26,865 | 41.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 538 | 1,592 | $55,627 | $14,186 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 200 | 272 | $31,280 | $12,108 | 38.7% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 366 | 368 | $12,880 | $12,066 | 93.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 56 | 61 | $21,960 | $11,559 | 52.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 346 | 349 | $12,215 | $10,269 | 84.1% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 95 | 106 | $13,250 | $9,857 | 74.4% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 195 | 247 | $24,650 | $9,708 | 39.4% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 122 | 144 | $21,600 | $7,140 | 33.1% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 45 | 51 | $14,858 | $6,849 | 46.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 122 | 280 | $11,200 | $4,391 | 39.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 57 | 57 | $15,390 | $4,114 | 26.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 27 | 28 | $7,140 | $3,857 | 54.0% |
| 0240U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid-19), influenza a, and influenza b) in upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 22 | 22 | $6,408 | $3,075 | 48.0% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 19 | 1,064 | $12,768 | $2,774 | 21.7% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 62 | 83 | $11,620 | $2,759 | 23.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 14 | 14 | $3,500 | $2,104 | 60.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 33 | 33 | $5,775 | $1,902 | 32.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 68 | 82 | $8,200 | $1,806 | 22.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $5,100 | $1,594 | 31.2% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2023 | 22 | 22 | $3,300 | $1,264 | 38.3% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 72 | 72 | $3,240 | $1,187 | 36.6% |
About Dr. Mark Cline, M.D
Dr. Mark Cline, M.D is a Family Medicine healthcare provider based in Nacogdoches, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477563898.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Cline, M.D has received a total of $12,124 in payments from pharmaceutical and medical device companies, with $1,128 received in 2024. These payments were reported across 788 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($12,099).
As a Medicare-enrolled provider, Cline has provided services to 27,778 Medicare beneficiaries, totaling 123,093 services with total Medicare billing of $2.6M. Data is available for 4 years (2020–2023), covering 185 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Nacogdoches, TX
- Active Since 08/08/2006
- Last Updated 08/25/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1477563898
Products in Payments
- FARXIGA (Drug) $1,420
- VRAYLAR (Drug) $998.70
- Ozempic (Drug) $435.87
- UBRELVY (Drug) $401.30
- JANUVIA (Drug) $397.70
- SYMBICORT (Drug) $327.54
- JARDIANCE (Drug) $308.93
- Aimovig (Biological) $295.88
- ELIQUIS (Drug) $260.09
- CHANTIX (Drug) $243.55
- Trintellix (Drug) $236.09
- BELSOMRA (Drug) $220.91
- EUCRISA (Drug) $215.15
- TRULICITY (Drug) $194.54
- Edarbi (Drug) $185.94
- BREZTRI (Drug) $184.99
- LYRICA (Drug) $183.74
- Dexcom G6 Transmitter (Medical Supply) $183.47
- Veozah (Drug) $181.15
- BEVESPI AEROSPHERE (Drug) $167.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Nacogdoches
Dr. Kelley Moon, M.d, M.D
Family Medicine — Payments: $9,736
Family Medicine $9,736
Eric Cline, Md, MD
Family Medicine — Payments: $6,904
Family Medicine $6,904
Rachel Cline
Family Medicine — Payments: $6,628
Family Medicine $6,628
Dr. Philip Labarbera, M.d, M.D
Family Medicine — Payments: $5,195
Family Medicine $5,195
Bryan Davis, M.d, M.D
Family Medicine — Payments: $2,951
Family Medicine $2,951
Dr. Wilburn Furniss, M.d, M.D
Family Medicine — Payments: $2,314
Family Medicine $2,314